Showing 12 out of 17 results
Herbert Smith Freehills advises joint sponsors on MedSci Healthcare's Hong Kong IPO 史密夫斐尔律师事务所作为联席保荐人律师为梅斯健康香港上市提供法律服务
Leading international law firm Herbert Smith Freehills has advised China International Capital Corporation Hong Kong Securities Limited, and Macquarie …
Herbert Smith Freehills advises CICC as the sole sponsor on LEPU ScienTech's Hong Kong IPO 史密夫斐尔律师事务所作为独家保荐人中金公司律师为乐普心泰医疗香港上市提供法律服务
Leading international law firm Herbert Smith Freehills has advised China International Capital Corporation as the sole sponsor of LEPU ScienTech Medical …
Herbert Smith Freehills advises sponsors on Jenscare's Hong Kong IPO 史密夫斐尔律师事务所作为保荐人律师为健世科技香港上市提供法律服务
Leading international law firm Herbert Smith Freehills has advised China International Capital Corporation and Citigroup as joint sponsors of Jenscare …
Herbert Smith Freehills advises Sanofi on €300 million equity investment in Innovent 史密夫斐尔律师事务所就赛诺菲对信达生物3亿欧元股权投资提供法律服务
Leading international law firm Herbert Smith Freehills has advised innovative global healthcare company Sanofi on its €300 million strategic equity …
Herbert Smith Freehills advises sole sponsor on Rainmed Medical Limited's Hong Kong IPO 史密夫斐尔律师事务所作为独家保荐人律师为润迈德医疗香港上市提供法律服务
Leading international law firm Herbert Smith Freehills has advised Huatai Financial Holdings as the sole sponsor of medical device company Rainmed …
Herbert Smith Freehills advises on Shanghai HeartCare Medical's HK$1.13 billion Hong Kong IPO 史密夫斐尔律师事务所为心玮医疗11.3亿港元IPO提供法律服务
Leading global law firm Herbert Smith Freehills has advised neuro-interventional medical device manufacturer Shanghai HeartCare Medial Technology …
Herbert Smith Freehills advises sponsors on CARsgen Therapeutics’ HK$3.1 billion Hong Kong IPO 史密夫斐尔律师事务所作为联席保荐人境外律师为科济药业31亿港元IPO提供法律服务
Leading global law firm Herbert Smith Freehills has advised Goldman Sachs and UBS as joint sponsors of biopharmaceutical company CARsgen Therapeutics …
2020 Australian IPO Review: IPOs by the numbers
A challenging year Market conditions in 2020 unfolded like an obstacle course and were significantly impacted by the onset of the Covid-19 pandemic, …
2020 Australian IPO Review: Key themes
2020 in review Market conditions in 2020 were of course impacted by the Covid-19 pandemic, but also by record low interest …
Australian IPOs defy early expectations to achieve record end to 2020
The outlook for Australian IPO activity in 2021 is promising following a spate of listings on the ASX in the second half of 2020, according to a new …
Herbert Smith Freehills advises sponsors on Antengene’s HK$2.6 billion Hong Kong IPO / 史密夫斐尔律师事务所作为联席保荐人境外律师为德琪医药26亿港元IPO提供法律服务
Leading global law firm Herbert Smith Freehills has advised Goldman Sachs and JP Morgan as joint sponsors of biopharmaceutical company Antengene …
Herbert Smith Freehills advises sponsors on Simcere Pharmaceutical’s HK$3.57 billion Hong Kong IPO / 史密夫斐尔律师事务所作为联席保荐人境外律师为先声药业35.7亿港元IPO提供法律服务
Leading global law firm Herbert Smith Freehills has advised Morgan Stanley Asia Limited and China International Capital Corporation Hong Kong Securities …
Showing 12 out of 17 results
View more